https://www.biospace.com/gri-bio-reports-first-quarter-2024-financial-results-and-provides-corporate-update
GRI Bio Reports First Quarter 2024 Financial Results and Provides Corporate Update - BioSpace
May 13, 2024 - GRI Bio, Inc. today reported its financial results for the first quarter ended March 31, 2024 and provided a corporate update.
bio reportsfirst quarterfinancial resultscorporate updategri
https://www.finanznachrichten.de/nachrichten-2025-08/66105247-q32-bio-reports-second-quarter-2025-financial-results-and-provides-corporate-update-008.htm
Q32 Bio Reports Second Quarter 2025 Financial Results and Provides Corporate Update
-- Dosing of patients in Part A open-label extension (OLE) and Part B of SIGNAL-AA ongoing; SIGNAL-AA Part B topline data readout on-track for 1H'26 -- --...
bio reportssecond quarterfinancial resultscorporate updateprovides
https://www.clinicaltrialsarena.com/news/hi-bio-trial-kidney-transplant/
HI-Bio reports findings from trial in kidney transplant recipients
May 27, 2024 - HI-Bio has reported positive outcomes from the Phase II trial of felzartamab, in treating late AMR in kidney transplant recipients.
bio reportskidney transplanthifindingstrial
https://pharmashots.com/21791/endevica-bio-reports-the-first-patient-dosing-in-p-ii-study-evaluating-tcmcb07-b07/
Endevica Bio Reports the First Patient Dosing in P-II Study Evaluating TCMCB07 (B07) - PharmaShots
May 1, 2025 - Shots: Ref: Prnewswire | Image: Endevica Bio Related News:- Eli Lilly Reported the Data from P-III (ACHIEVE-1) Trial Evaluating an Oral GLP-1, Orforglipron...
bio reportsthe firstpatientdosingii
https://amsterdamaesthetics.com/multicultural/granata-bio-reports-strong-enrollment-momentum-in-pivotal-phase-iii-grace-study-of-investigational-gonadotropin-for-assisted-reproductive-technology/
Granata Bio Reports Strong Enrollment Momentum in Pivotal Phase III GRACE Study of Investigational...
Dec 14, 2025 - BOSTON, Dec. 3, 2025 /PRNewswire/ -- Granata Bio Corporation, a biotechnology company advancing innovative reproductive health solutions, announced strong...
bio reportsphase iiigrace studystrongenrollment
https://finviz.com/news/333380/boundless-bio-reports-fourth-quarter-and-full-year-2025-financial-results-and-business-highlights
Boundless Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights
Stock screener for investors and traders, financial visualizations.
bio reportsfull yearfinancial resultsbusiness highlightsboundless
https://markets.businessinsider.com/news/stocks/cabaletta-bio-reports-third-quarter-2025-financial-results-and-provides-business-update-1035532581
Cabaletta Bio Reports Third Quarter 2025 Financial Results and Provides Business Update | Markets...
Rese-cel data presented at multiple medical meetings demonstrated potentially transformative, drug-free clinical responses with a favorable safety...
bio reportsthird quarterfinancial resultsbusiness updateprovides
https://wiseek.ai/ticker/clym/climb-bio-reports-reduced-q1-net-loss-confirms-cash-runway-into-2028-and-details-110m-private-placement-000119312526210357/
Climb Bio Reports Reduced Q1 Net Loss, Confirms Cash Runway into 2028, and Details $110M Private...
May 7, 2026 - Climb Bio reported a reduced net loss for Q1 2026 and confirmed a strong cash position.
bio reportscash runwayclimbreducedloss
https://agfundernews.com/pivot-bio-talks-insets-vs-offsets-paying-farmers-and-why-nitrous-oxide-is-an-overlooked-emission
Pivot Bio reports $6m paid to growers fixing nitrogen
Mar 18, 2024 - Pivot Bio talks insets versus offset programs, paying farmers, and why nitrous oxide is an overlooked emission
bio reportspivotpaidgrowersfixing
https://markets.financialcontent.com/stocks/article/gnwcq-2026-3-13-barinthus-bio-reports-full-year-2025-financial-results-and-updates-on-corporate-developments
FinancialContent - Barinthus Bio Reports Full Year 2025 Financial Results and Updates on Corporate...
Barinthus Bio Reports Full Year 2025 Financial Results and Updates on Corporate Developments
results and updatesbio reportsfull yearfinancialcorporate
https://www.site24x7.com/security-reports/bio-rad-laboratories-inc
Bio-Rad Laboratories, Inc. security reports and ratings
Get free security reports and industry-wise security ratings with Digital Risk Analyzer. Assess vulnerabilities and enhance your cybersecurity strategy today!
security reportsbioradlaboratoriesinc
https://flcube.com/?p=7084
Bio-Thera Solutions Reports 54.86% YOY Revenue Growth in 2023, Led by Biosimilar Sales - Insight,...
Oct 16, 2024 - Bio-Thera Solutions (SHA: 688177), a biopharmaceutical company headquartered in Guangzhou, has announced its financial results for 2023, reporting revenues of...
revenue growthbiotherasolutionsreports
https://reports.the-star.co.ke/archives/3112
Rachel Levins Boyfriend: Tyler Regan, Web Value, Instagram, Age, Bio, Career | Star Reports
rachelboyfriendtylerreganweb